In our study, we found that EPDR1 was downregulated in EOC tissue samples, and low EPDR1 was associated with tumor progression and poor prognosis in EOC patients by analysis of TCGA, GTEx, GEO and CPTAC dataset, RT-PCR, Western blot, and IHC. Here, EPDR1 is linked to neoplasm.